Ontology highlight
ABSTRACT:
SUBMITTER: Trinks J
PROVIDER: S-EPMC5378445 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
Trinks Julieta J Caputo Mariela M Hulaniuk María L ML Corach Daniel D Flichman Diego D
Pharmacogenomics and personalized medicine 20170328
In recent years, great progress has been made in the field of new therapeutic options for hepatitis C virus (HCV) infection. The new direct-acting antiviral agents (DAAs) represent a great hope for millions of chronically infected individuals because their use may lead to excellent cure rates with fewer side effects. In Latin America, the high prevalence of HCV genotype 1 infection and the significant association of Native American ancestry with risk predictive single-nucleotide polymorphisms (S ...[more]